Aurobindo Pharma’s US subsidiary - Auromedics Pharma LLC has initiated voluntary recall of over 1.5 million bags of different antibiotic and anti-seizure injections from the US market due to lack of assurance of sterility.
The company started recalling nearly 0.4 million bags of Linezolid Injection 600 mg per 300 mL (2 mg/mL) for Intravenous Administration, 0.67 million bags of Levofloxacin in 5 % Dextrose Injection of different strengths and 0.52 million of Levetiracetam of different strengths.
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.
